Related references
Note: Only part of the references are listed.Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal
Matteo A. Manini et al.
DIGESTIVE AND LIVER DISEASE (2018)
Is Hepatitis B Immune Globulin Still Needed After Liver Transplantation for Chronic Hepatitis B?
Edward J. Gane
HEPATOLOGY (2017)
Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients
Kavita Radhakrishnan et al.
TRANSPLANTATION (2017)
Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients
P. Lampertico et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients
I. Fernandez et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence
Evangelos Cholongitas et al.
TRANSPLANT INTERNATIONAL (2014)
One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation
Tomohiro Tanaka et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
E. Cholongitas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective
D. J. W. Wesdorp et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Post-transplantation sequential entecavir monotherapy following 1-year combination therapy with hepatitis B immunoglobulin
Nam-Joon Yi et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes
Patrizia Burra et al.
JOURNAL OF HEPATOLOGY (2013)
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigenpositive liver transplant candidates
Edward J. Gane et al.
LIVER TRANSPLANTATION (2013)
Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation
Lewis W. Teperman et al.
LIVER TRANSPLANTATION (2013)
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
Rene Adam et al.
JOURNAL OF HEPATOLOGY (2012)
Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation
R. Todd Stravitz et al.
LIVER INTERNATIONAL (2012)
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation
E. Cholongitas et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Posttransplantation Hepatitis B Prophylaxis with Combination Oral Nucleoside and Nucleotide Analog Therapy
S. Saab et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis
L. H. Katz et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States
W. Ray Kim et al.
GASTROENTEROLOGY (2009)
Recurrence of Hepatocellular Carcinoma and Hepatitis B Reinfection in Hepatitis B Surface Antigen-Positive Patients After Liver Transplantation
Sammy Saab et al.
LIVER TRANSPLANTATION (2009)
Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation
Luciana C. Faria et al.
GASTROENTEROLOGY (2008)
Survival after liver transplantation in the United Kingdom and Ireland compared with the United States
M. F. Dawwas et al.
GUT (2007)
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants
A Marzano et al.
LIVER TRANSPLANTATION (2005)
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence
A Marzano et al.
LIVER TRANSPLANTATION (2005)
A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation
RJ Fontana et al.
LIVER TRANSPLANTATION (2001)
Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation
Z Ben-Ari et al.
LIVER TRANSPLANTATION (2001)
Share Paper
